Recommendations on Monitoring and Replacement of Antithrombin, Fibrinogen, and Von Willebrand Factor in Pediatric Patients on Extracorporeal Membrane Oxygenation: The Pediatric Extracorporeal Membrane Oxygenation Anticoagulation CollaborativE Consensus Conference
Nicole D. Zantek(Purdue University West Lafayette), Kevin Watt(University of Utah), Leslie Raffini(Children's Hospital of Philadelphia), Jennifer A. Muszynski(Nationwide Children's Hospital), Peta Alexander(Boston Children's Hospital), Lisa Baumann Kreuziger(Medical College of Wisconsin), Elizabeth Lyman(Nationwide Children's Hospital), Alison Gehred(Nationwide Children's Hospital), Marie E. Steiner(Boston University), Jun Teruya(Baylor College of Medicine)
Cited by 12
Related Papers
Extracorporeal membrane oxygenation support in COVID-19: an international cohort study of the Extracorporeal Life Support Organization registry
|The Lancet|2020|945
Age-dependent effects of RPE65 gene therapy for Leber's congenital amaurosis: a phase 1 dose-escalation trial
|The Lancet|2009|864
Effects of Red-Cell Storage Duration on Patients Undergoing Cardiac Surgery
|New England Journal of Medicine|2015|489
Maternal morbidity in patients with morbidly adherent placenta treated with and without a standardized multidisciplinary approach
|American Journal of Obstetrics and Gynecology|2014|476
Red Blood Cell Transfusion
|JAMA|2023|359